Bruno Daubeuf

961 total citations
20 papers, 663 citations indexed

About

Bruno Daubeuf is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Bruno Daubeuf has authored 20 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 8 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Bruno Daubeuf's work include Immune Response and Inflammation (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immune Cell Function and Interaction (8 papers). Bruno Daubeuf is often cited by papers focused on Immune Response and Inflammation (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immune Cell Function and Interaction (8 papers). Bruno Daubeuf collaborates with scholars based in Switzerland, United States and France. Bruno Daubeuf's co-authors include Greg Elson, Jérôme Pugin, Irène Dunn-Siegrist, Marie Kosco‐Vilbois, Hermann Wagner, Carsten J. Kirschning, Walter Ferlin, Suzanne Herren, Michael A. Matthay and Marina A. Freudenberg and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Bruno Daubeuf

17 papers receiving 648 citations

Peers

Countries citing papers authored by Bruno Daubeuf

Since Specialization

Citations

This map shows the geographic impact of Bruno Daubeuf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Daubeuf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Daubeuf more than expected).

Fields of papers citing papers by Bruno Daubeuf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Daubeuf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Daubeuf. The network helps show where Bruno Daubeuf may publish in the future.

Co-authorship network of co-authors of Bruno Daubeuf

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Daubeuf. A scholar is included among the top collaborators of Bruno Daubeuf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Daubeuf. Bruno Daubeuf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Selective activation of interleukin-2/interleukin-15 receptor signaling in tumor microenvironment using paired bispecific antibodies 2025 ·Journal for ImmunoTherapy of Cancer ·(unknown), Eric Hatterer, Laurence Chatel, (unknown), (unknown), Bruno Daubeuf, (unknown), Pauline Malinge, Sébastien Calloud, Krzysztof Masternak, (unknown), Nicolas Fischer, Camilla Jandus, (unknown)	0
2	Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody 2024 ·Frontiers in Immunology ·Anja Seckinger, Vanessa Buatois, Valéry Moine, Bruno Daubeuf, Françoise Richard, Laurence Chatel, (unknown), (unknown), (unknown), Krzysztof Masternak, (unknown), (unknown), (unknown), (unknown), Yves Poitevin, Dirk Hose	2
3	CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model 2022 ·Experimental Hematology and Oncology ·Xavier Chauchet, Laura Cons, Laurence Chatel, Bruno Daubeuf, Gérard Didelot, Valéry Moine, Didier Chollet, Pauline Malinge, Guillemette Pontini, Krzysztof Masternak, Walter Ferlin, Vanessa Buatois, Limin Shang	20
4	752P Novel CEAxCD3 (NILK-2301) and CEAxCD28 (NILK-3301) κλ bispecific antibodies for next generation immunotherapy of CEA-expressing cancer 2022 ·Annals of Oncology ·(unknown), (unknown), Valéry Moine, (unknown), Bruno Daubeuf, Vanessa Buatois, Franck Gueneau, Ulla Ravn, Krzysztof Masternak, Yves Poitevin, Giovanni Magistrelli, Pauline Malinge, (unknown), Nicolas Fischer, (unknown), Walter Ferlin, (unknown)	1
5	853 Novel CEAxCD47 (NILK-2401) and CEAxCD3 (NILK-2301) kl bispecific antibodies for multimodal immunotherapy of CEA-expressing solid cancer 2022 ·Regular and Young Investigator Award Abstracts ·Anja Seckinger, Vanessa Buatois, Valéry Moine, (unknown), Bruno Daubeuf, (unknown), Ulla Ravn, (unknown), Krzysztof Masternak, Yves Poitevin, Giovanni Magistrelli, Pauline Malinge, (unknown), Nicolas Fischer, K. Strein, Walter Ferlin, Dirk Hose	0
6	Co-engaging CD47 and CD19 with a bispecific antibody abrogates B-cell receptor/CD19 association leading to impaired B-cell proliferation 2018 ·mAbs ·Eric Hatterer, Leticia Barba, Nelly Noraz, Bruno Daubeuf, (unknown), (unknown), Françoise Richard, Marie Kosco‐Vilbois, Walter Ferlin, Limin Shang, Vanessa Buatois	31
7	A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease 2016 ·Arthritis Research & Therapy ·Eric Hatterer, Limin Shang, Pierre Simonet, Suzanne Herren, Bruno Daubeuf, (unknown), James H. Reilly, Greg Elson, Robert Nelson, Cem Gabay, Jeremy Sokolove, Iain B. McInnes, Marie Kosco‐Vilbois, Walter Ferlin, (unknown), Cristina de Min	29
8	Bispecific antibody targeting of CD47/CD19 to promote enhanced phagocytosis of patient B lymphoma cells. 2015 ·Journal of Clinical Oncology ·Zoë Johnson, Anne Papaioannou, Lucie Bernard, Emilio Cosimo, Bruno Daubeuf, Françoise Richard, Xavier Chauchet, Valéry Moine, Lucile Broyer, Limin Shang, Maureen R. Deehan, Nicolas Fischer, Krzysztof Masternak, Marie Kosco‐Vilbois, Alison M. Michie, Walter Ferlin	7
9	Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors 2014 ·mAbs ·(unknown), Pauline Malinge, Bruno Daubeuf, Limin Shang, Greg Elson, Marie Kosco‐Vilbois, Nicolas Fischer, François Rousseau	7
10	Enhancement of Islet Engraftment and Achievement of Long-Term Islet Allograft Survival by Toll-Like Receptor 4 Blockade 2014 ·Transplantation ·Laurianne Giovannoni, Yannick D. Müller, Stéphanie Lacotte, Géraldine Parnaud, Sophie Borot, Raphaël Meier, Vanessa Lavallard, Benoît Bédat, Christian Toso, Bruno Daubeuf, Greg Elson, Limin Shang, Philippe Morel, Marie Kosco‐Vilbois, Domenico Bosco, Thierry Berney	16
11	Characterization of a surrogate murine antibody to model anti-human CD3 therapies 2013 ·mAbs ·(unknown), Eric Hatterer, (unknown), Bruno Daubeuf, Laura Cons, Sophie Glatt, Walter Reith, Marie Kosco‐Vilbois, Yann Dean	7
12	O033 Ligand-independent blockade of TLR4 activation represents a promising strategy to protect from inflammatory disease pathogenesis in islet-transplantation 2012 ·Cytokine ·Bruno Daubeuf, Laurianne Giovannoni, (unknown), Greg Elson, Walter Ferlin, Marie Kosco‐Vilbois, Thierry Berney, Limin Shang	1
13	NI-0101, a Therapeutic TLR4 Monoclonal Antibody for Rheumatoid Arthritis 2011 ·Oxford University Research Archive (ORA) (University of Oxford) ·Greg Elson, Theresa H. Page, Vanessa Buatois, Bruno Daubeuf, Laurence Chatel, Laura Cons, (unknown), (unknown), Walter Ferlin, Marie Kosco‐Vilbois, Kim S. Midwood, (unknown)	5
14	Robust recombinant FcRn production in mammalian cells enabling oriented immobilization for IgG binding studies 2011 ·Journal of Immunological Methods ·Giovanni Magistrelli, Pauline Malinge, Nadia Anceriz, (unknown), (unknown), Sébastien Calloud, Bruno Daubeuf, Marie Kosco‐Vilbois, Nicolas Fischer	14
15	TLR4-induced IFN-γ production increases TLR2 sensitivity and drives Gram-negative sepsis in mice 2008 ·The Journal of Experimental Medicine ·(unknown), Greg Elson, Ruth Ferstl, Stefan Dreher, Thomas Mueller, Marina A. Freudenberg, Bruno Daubeuf, Hermann Wagner, Carsten J. Kirschning	100
16	TLR4/MD-2 Monoclonal Antibody Therapy Affords Protection in Experimental Models of Septic Shock 2007 ·The Journal of Immunology ·Bruno Daubeuf, John C. Mathison, (unknown), Stéphanie Hugues, Suzanne Herren, Walter Ferlin, Marie Kosco‐Vilbois, Hermann Wagner, Carsten J. Kirschning, Richard J. Ulevitch, Greg Elson	99
17	Pivotal Involvement of Fcγ Receptor IIA in the Neutralization of Lipopolysaccharide Signaling via a Potent Novel Anti-TLR4 Monoclonal Antibody 15C1 2007 ·Journal of Biological Chemistry ·Irène Dunn-Siegrist, (unknown), Bruno Daubeuf, Yves Poitevin, (unknown), Suzanne Herren, Marie Kosco‐Vilbois, Yann Dean, Jérôme Pugin, Greg Elson	43
18	Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria 2006 ·Blood ·Greg Elson, Irène Dunn-Siegrist, Bruno Daubeuf, Jérôme Pugin	172
19	Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock 2004 ·Blood ·Jérôme Pugin, (unknown), Bruno Daubeuf, Michael A. Matthay, Greg Elson, Irène Dunn-Siegrist	79
20	Gene expression of Toll-like receptor-2, Toll-like receptor-4, and MD2 is differentially regulated in rabbits with Escherichia coli pneumonia 2004 ·Gene ·Osamu Kajikawa, Charles W. Frevert, Shu‐Min Lin, Richard B. Goodman, (unknown), Venus Wong, (unknown), Bruno Daubeuf, Greg Elson, Thomas R. Martin	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact